De Chao Yu
Patrimonio netto: 1 217 M $ in data 31/07/2026
Patrimonio netto: 1 217 M $ in data 31/07/2026
Fondatore di Innovent Biologics, Inc. e Chengdu Kanghong Pharmaceutical Group Co., Ltd., De Chao Yu occupa la posizione di presidente e amministratore delegato di Innovent Biologics, Inc. e presidente della Chinese Antibody Society. È anche nel consiglio di amministrazione di Babytree Group e Cheerwin Group Ltd. e professore all'Università di Sichuan. De Chao Yu è stato in precedenza presidente e amministratore delegato di Chengdu Kanghong Pharmaceutical Group Co., Ltd., vicepresidente di ricerca e sviluppo di Applied Genetic Technologies Corp., vicepresidente di ricerca e sviluppo di Applied Genetics, Inc., presidente e amministratore delegato di Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd., Vice Presidente-Ricerca e Sviluppo di Calyon North America, Inc., Vice Presidente di Calydon, Inc. e Direttore Generale di China Medicinal Biotech Association. Ha ricevuto un dottorato dall'Accademia cinese delle scienze.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/05/2026 | 110.058.657 ( 6,32% ) | 1 217 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Amministratore Delegato | 28/04/2011 |
| DIAN DIAGNOSTICS GROUP CO.,LTD. | Direttore/Membro del Consiglio | 03/11/2023 |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
Chinese Antibody Society
Chinese Antibody Society Miscellaneous Commercial ServicesCommercial Services Engages in therapeutic antibodies services | Presidente | 01/01/2017 |
| Società | Posizione | Fine |
|---|---|---|
| BABYTREE GROUP | Direttore/Membro del Consiglio | 10/05/2023 |
| CHEERWIN GROUP LIMITED | Direttore/Membro del Consiglio | 14/10/2022 |
China Medicinal Biotech Association | Corporate Officer/Principal | 01/01/2019 |
| PHARMABLOCK SCIENCES (NANJING), INC. | Direttore/Membro del Consiglio | 01/01/2018 |
| CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD | Amministratore Delegato | 01/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Calydon, Inc.
Calydon, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products for cancer | Health Technology |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calyon North America, Inc.
Calyon North America, Inc. Regional BanksFinance Part of SAS Rue la Boétie, Calyon North America, Inc. is a company based in New York, NY. | Finance |
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells traditional Chinese and biologic drugs | Health Technology |
China Medicinal Biotech Association | |
Dian Diagnostics Group Co. Ltd.
Dian Diagnostics Group Co. Ltd. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
Innovent Biologics, Inc.
Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Applied Genetics, Inc.
Applied Genetics, Inc. Applied Genetics Laboratories, Inc. is a company that specializes in cytogenetic analysis and genomic research for the medical and pharmaceutical industries. The company offers state-of-the-art cytogenetics analysis services, including karyotyping and fluorescence in situ hybridization (Fish) studies, that are tailored to meet the unique needs of their clients while ensuring compliance with FDA Good Laboratory Practice regulations. The company also provides Hybloc™ DNA and normal human metaphase slides for genomic research, contributing to groundbreaking research in medicine, vaccine production, and tissue engineering. The company has been delivering GLP-compliant cytogenomic characterization and species verification for over 30 years and is led by a team of industry experts. The company is based in Brookings, SD. | |
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd.
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
PharmaBlock Sciences (Nanjing), Inc.
PharmaBlock Sciences (Nanjing), Inc. Miscellaneous Commercial ServicesCommercial Services Provides technical services related to the research and development of drug molecular building blocks and process production | Commercial Services |
Babytree Group
Babytree Group Advertising/Marketing ServicesCommercial Services Provides advertising and e-Commerce services | Commercial Services |
Chinese Antibody Society
Chinese Antibody Society Miscellaneous Commercial ServicesCommercial Services Engages in therapeutic antibodies services | Commercial Services |
Cheerwin Group Ltd.
Cheerwin Group Ltd. Chemicals: AgriculturalProcess Industries Develops, manufactures and sells online household & personal care and pet products | Process Industries |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale